Key points are not available for this paper at this time.
Hepatocellular carcinoma (HCC), which ranks globally as the third leading cause of cancer-related deaths, is highly prevalent, and most patients are diagnosed with advanced-stage cancer when treatments are largely ineffective. 1 Thus, there is an urgent need for earlier diagnosis to improve HCC patient outcomes.
Xue et al. (Wed,) studied this question.